These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 28844758

  • 1. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
    Alibolandi M, Abnous K, Mohammadi M, Hadizadeh F, Sadeghi F, Taghavi S, Jaafari MR, Ramezani M.
    J Control Release; 2017 Oct 28; 264():228-236. PubMed ID: 28844758
    [Abstract] [Full Text] [Related]

  • 2. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L, Badiee A, Mosaffa F, Jaafari MR.
    J Control Release; 2015 Dec 28; 220(Pt A):275-286. PubMed ID: 26518722
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy.
    Gabizon AA.
    Cancer Invest; 2001 Dec 28; 19(4):424-36. PubMed ID: 11405181
    [Abstract] [Full Text] [Related]

  • 8. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M, Gheybi F, Rezayat SM, Jaafari MR.
    Eur J Pharm Sci; 2016 Apr 30; 86():125-35. PubMed ID: 26972276
    [Abstract] [Full Text] [Related]

  • 9. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
    Oroojalian F, Babaei M, Taghdisi SM, Abnous K, Ramezani M, Alibolandi M.
    J Control Release; 2018 Oct 28; 288():45-61. PubMed ID: 30171978
    [Abstract] [Full Text] [Related]

  • 10. The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model.
    Rizzitelli S, Giustetto P, Faletto D, Delli Castelli D, Aime S, Terreno E.
    J Control Release; 2016 May 28; 230():57-63. PubMed ID: 27049069
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of pharmacokinetics, tissue distribution and pharmacodynamics of liposomal and free doxorubicin in tumour-bearing mice following intratumoral injection.
    Ren S, Li C, Dai Y, Li N, Wang X, Tian F, Zhou S, Qiu Z, Lu Y, Zhao D, Chen X, Chen D.
    J Pharm Pharmacol; 2014 Sep 28; 66(9):1231-9. PubMed ID: 24716458
    [Abstract] [Full Text] [Related]

  • 14. The Comparison of Biodistribution, Efficacy and Toxicity of Two PEGylated Liposomal Doxorubicin Formulations in Mice Bearing C-26 Colon Carcinoma: a Preclinical Study.
    Razavi-Azarkhiavi K, Jafarian AH, Abnous K, Razavi BM, Shirani K, Zeinali M, Jaafari MR, Karimi G.
    Drug Res (Stuttg); 2016 Jun 28; 66(6):330-6. PubMed ID: 27022719
    [Abstract] [Full Text] [Related]

  • 15. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

  • 17. A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.
    Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV.
    J Control Release; 2013 May 28; 168(1):61-9. PubMed ID: 23474033
    [Abstract] [Full Text] [Related]

  • 18. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
    Nik ME, Malaekeh-Nikouei B, Amin M, Hatamipour M, Teymouri M, Sadeghnia HR, Iranshahi M, Jaafari MR.
    Sci Rep; 2019 Jul 02; 9(1):9527. PubMed ID: 31267009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.